Analysis | Metabolite Name | Measured Value | Units | Exercise | Group | Sex | Type |
---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 1169 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 1939 | Peak area normalized | No | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 2183 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 3013 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 3328 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 3461 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 3960 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 4444 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 4948 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 5023 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 5066 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 5607 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 5792 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 5801 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 5806 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 6218 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 6572 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 6792 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 6831 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 7089 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 7096 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 7255 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 7412 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 7592 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 7922 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 7946 | Peak area normalized | No | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 7953 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 8058 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 8278 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 8280 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 8714 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 8765 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 9190 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 9251 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 9781 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 10166 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 10336 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 10687 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 10698 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 10739 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 10742 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 10859 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11048 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11069 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11201 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11299 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11360 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11522 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11586 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11591 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11640 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11761 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11767 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 11797 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 12271 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 12288 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 12349 | Peak area normalized | No | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 12404 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 12844 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 13100 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 13261 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 13395 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 13404 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 13830 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 13845 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14036 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14046 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14101 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14144 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14310 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14454 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14610 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14622 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14830 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 14881 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15079 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15380 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15389 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15402 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15458 | Peak area normalized | Yes | LowRisk | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15514 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15527 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15529 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15531 | Peak area normalized | No | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15688 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15702 | Peak area normalized | Yes | PAH | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15711 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15838 | Peak area normalized | Yes | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 15940 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16098 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16155 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16172 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16192 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16252 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16264 | Peak area normalized | No | Healthy | Male | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16309 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16338 | Peak area normalized | Yes | Borderline Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16554 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16637 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16672 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16869 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 16928 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17112 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17202 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17309 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17422 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17447 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17614 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17619 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17628 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17634 | Peak area normalized | No | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17743 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17935 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 17999 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 18074 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 18322 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 18340 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 18451 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 18478 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 18562 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 18649 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 18833 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 19268 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 19511 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 19769 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 20957 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 21195 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 21391 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 21805 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 22693 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 22778 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 22946 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 25345 | Peak area normalized | No | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 25625 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 26071 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 26265 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 26310 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 27810 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 28965 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 29104 | Peak area normalized | Yes | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 29946 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 31509 | Peak area normalized | No | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 32217 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 34251 | Peak area normalized | Yes | Healthy | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 35388 | Peak area normalized | No | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 35608 | Peak area normalized | Yes | PAH | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 36802 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 40641 | Peak area normalized | No | Borderline Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 45450 | Peak area normalized | Yes | LowRisk | Female | Non-invasive |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 46118 | Peak area normalized | Yes | Normal Pressures | Female | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | 48630 | Peak area normalized | Yes | Normal Pressures | Male | Cath |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | No | Borderline Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | No | Borderline Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | No | Healthy | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | No | Healthy | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | No | LowRisk | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | No | Normal Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | No | PAH | Female | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | No | PAH | Male | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | Yes | Borderline Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | Yes | Borderline Pressures | Male | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | Yes | Healthy | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | Yes | Healthy | Male | Non-invasive | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | Yes | LowRisk | Female | Non-invasive | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | Yes | Normal Pressures | Female | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | Yes | PAH | Female | Cath | |
Reversed phase NEGATIVE ION MODE | GLYCERIC ACID (M-H)- | Peak area normalized | Yes | PAH | Male | Cath |